Kit receptor dimerization is driven by bivalent binding of stem cell factor
- PMID: 9045650
- DOI: 10.1074/jbc.272.10.6311
Kit receptor dimerization is driven by bivalent binding of stem cell factor
Abstract
Most growth factors and cytokines activate their receptors by inducing dimerization upon binding. We have studied binding of the dimeric cytokine stem cell factor (SCF) to the extracellular domain of its receptor Kit, which is a receptor tyrosine kinase similar to the receptors for platelet-derived growth factor and colony-stimulating factor-1. Calorimetric studies show that one SCF dimer binds simultaneously to two molecules of the Kit extracellular domain. Gel filtration and other methods show that this results in Kit dimerization. It has been proposed that SCF-induced Kit dimerization proceeds via a conformational change that exposes a key receptor dimerization site in the fourth of the five immunoglobulin (Ig)-like domains in Kit. We show that a form of Kit containing just the first three Ig domains (Kit-123) binds to SCF with precisely the same thermodynamic parameters as does Kit-12345. Analytical ultracentrifugation, light scattering, and gel filtration show that Kit-123 dimerizes upon SCF binding in a manner indistinguishable from that seen with Kit-12345. These data argue that the fourth Ig-like domain of Kit is not required for SCF-induced receptor dimerization and provide additional support for a model in which bivalent binding of the SCF dimer provides the driving force for Kit dimerization.
Similar articles
-
Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.EMBO J. 2000 Jul 3;19(13):3192-203. doi: 10.1093/emboj/19.13.3192. EMBO J. 2000. PMID: 10880433 Free PMC article.
-
Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor.J Biol Chem. 1992 Aug 5;267(22):15970-7. J Biol Chem. 1992. PMID: 1379243
-
Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.Cell. 2007 Jul 27;130(2):323-34. doi: 10.1016/j.cell.2007.05.055. Cell. 2007. PMID: 17662946
-
Early signaling pathways activated by c-Kit in hematopoietic cells.Int J Biochem Cell Biol. 1999 Oct;31(10):1053-74. doi: 10.1016/s1357-2725(99)00078-3. Int J Biochem Cell Biol. 1999. PMID: 10582339 Review.
-
Structure-function analyses of the kit receptor for the steel factor.Stem Cells. 1993 Jul;11 Suppl 2:12-21. doi: 10.1002/stem.5530110804. Stem Cells. 1993. PMID: 7691317 Review.
Cited by
-
Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches.Cancers (Basel). 2021 Nov 22;13(22):5847. doi: 10.3390/cancers13225847. Cancers (Basel). 2021. PMID: 34831002 Free PMC article. Review.
-
Role of dimerization of the membrane-associated growth factor kit ligand in juxtacrine signaling: the Sl17H mutation affects dimerization and stability-phenotypes in hematopoiesis.J Exp Med. 1998 May 4;187(9):1451-61. doi: 10.1084/jem.187.9.1451. J Exp Med. 1998. PMID: 9565637 Free PMC article.
-
Extracellular complexes of the hematopoietic human and mouse CSF-1 receptor are driven by common assembly principles.Structure. 2011 Dec 7;19(12):1762-72. doi: 10.1016/j.str.2011.10.012. Structure. 2011. PMID: 22153499 Free PMC article.
-
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.Eur J Haematol. 2013 Feb;90(2):89-98. doi: 10.1111/ejh.12043. Eur J Haematol. 2013. PMID: 23181448 Free PMC article. Review.
-
Autocrine/Paracrine Loop Between SCF+/c-Kit+ Mast Cells Promotes Cutaneous Melanoma Progression.Front Immunol. 2022 Jan 24;13:794974. doi: 10.3389/fimmu.2022.794974. eCollection 2022. Front Immunol. 2022. PMID: 35140718 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials